Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Clinical trial NCT07592273 · RECRUITING
Trial details
- NCT number
- NCT07592273
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.